메뉴 건너뛰기




Volumn 9, Issue 2, 2010, Pages 169-171

Sorafenib-induced psoriasiform eruption in a patient with metastatic thyroid carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; SORAFENIB; TRIAMCINOLONE; ANTINEOPLASTIC AGENT; BENZENESULFONIC ACID DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE;

EID: 77949894522     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (17)

References (13)
  • 4
    • 67650113975 scopus 로고    scopus 로고
    • Array of cutaneous adverse effects associated with sorafenib
    • Kong HH, Turner ML. Array of cutaneous adverse effects associated with sorafenib. J Am Acad Dermatol. 2009;61:360-361.
    • (2009) J Am Acad Dermatol , vol.61 , pp. 360-361
    • Kong, H.H.1    Turner, M.L.2
  • 5
    • 71949112710 scopus 로고    scopus 로고
    • Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib
    • Lee WJ, Lee JL, Chang SE, et al. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib. Br J Dermatol. 2009;161(5):1045-1051.
    • (2009) Br J Dermatol , vol.161 , Issue.5 , pp. 1045-1051
    • Lee, W.J.1    Lee, J.L.2    Chang, S.E.3
  • 6
    • 47849105015 scopus 로고    scopus 로고
    • Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor
    • DOI 10.1001/archderm.144.7.886
    • Autier J, Escudier B, Wechsler J, et al. Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor. Arch Dermatol. 2008;144:886-892. (Pubitemid 352039741)
    • (2008) Archives of Dermatology , vol.144 , Issue.7 , pp. 886-892
    • Autier, J.1    Escudier, B.2    Wechsler, J.3    Spatz, A.4    Robert, C.5
  • 8
    • 33845705260 scopus 로고    scopus 로고
    • Keratoacanthomas associated with sorafenib therapy
    • Kong HH, Cowen EW, Azad NS, et al. Keratoacanthomas associated with sorafenib therapy. J Am Acad Dermatol. 2007;56:171-172.
    • (2007) J Am Acad Dermatol , vol.56 , pp. 171-172
    • Kong, H.H.1    Cowen, E.W.2    Azad, N.S.3
  • 9
    • 65249127575 scopus 로고    scopus 로고
    • Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib
    • Dubauskas Z, Kunishige J, Prieto VG, et al. Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib. Clin Genitourin Cancer. 2009;7:20-23.
    • (2009) Clin Genitourin Cancer , vol.7 , pp. 20-23
    • Dubauskas, Z.1    Kunishige, J.2    Prieto, V.G.3
  • 11
    • 47049127786 scopus 로고    scopus 로고
    • Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses
    • Hipp MM, Hilf N, Walter S, et al. Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses. Blood. 2008;111:5610-5620.
    • (2008) Blood , vol.111 , pp. 5610-5620
    • Hipp, M.M.1    Hilf, N.2    Walter, S.3
  • 12
    • 0033762498 scopus 로고    scopus 로고
    • The EGF receptor: An essential regulator of multiple epidermal functions
    • Jost M, Kari C, Rodeck U. The EGF receptor: An essential regulator of multiple epidermal functions. Eur J Dermatol. 2000;10:505-510.
    • (2000) Eur J Dermatol , vol.10 , pp. 505-510
    • Jost, M.1    Kari, C.2    Rodeck, U.3
  • 13
    • 60549099595 scopus 로고    scopus 로고
    • Generalised erythematous skin eruptions induced by sorafenib: Cutaneous toxicity and treatment outcome
    • Galan Brotons A, Borras-Blasco J, Rosique-Robles JD, et al. Generalised erythematous skin eruptions induced by sorafenib: Cutaneous toxicity and treatment outcome. Clin Transl Oncol. 2008;10:844-846.
    • (2008) Clin Transl Oncol , vol.10 , pp. 844-846
    • Galan Brotons, A.1    Borras-Blasco, J.2    Rosique-Robles, J.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.